Oncotarget-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-11-10 李利光MedicalSCI

1睿禾 2018-09-13 00:00:00 发表:
有没有研究血液肿瘤方向的朋友？私信一下

睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下

334 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-10-24 zzzzfffvvv

热情不减，居然还有人在问

208 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-10-19 xianjiaotonglwf

不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表:
其他三个水刊是什么请问

151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问

256 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-27 医心唯你

大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表:
4月28投稿，8月1号接收，主要是编辑非常好

三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好

307 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-21 wsasdeffgcf

有有呀睿禾 2018-09-13 00:00:00 发表:
有没有研究血液肿瘤方向的朋友？私信一下

睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下

283 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-19 睿禾

oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表::
其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表:
其他三个水刊是什么请问

151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问

279 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-17 cancerwj

什么情况睿禾 2018-09-13 00:00:00 发表:
有没有研究血液肿瘤方向的朋友？私信一下

睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下

261 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-16 1210adeem17暂无昵称

其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表::
名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表:
名声不好.四大水刊.好学校发了别人看不上.

137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.

181 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-09-06 咔咔咔呀呀呀

难受。。。。。

251 0

[GetPortalCommentsPageByObjectIdResponse(id=563050, encodeId=81fc563050fb, content=1睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/0YRSb7hiaGZd2aaLDMFYWNLExl4CGxame7fM0Y2eBlhR0BOmz0YF3GJ0ZJvC1XfemUhOxCUXvKtZZFZn6b8XLpw/132, createdBy=f8c02319005, createdName=李利光MedicalSCI, createdTime=Sat Nov 10 00:00:00 CST 2018, time=2018-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562346, encodeId=1c26562346ac, content=热情不减，居然还有人在问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Wed Oct 24 00:00:00 CST 2018, time=2018-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562174, encodeId=f80e5621e4fa, content=不是四大水刊吗151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00481951856, createdName=xianjiaotonglwf, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561506, encodeId=9dfd5615069f, content=大哥厉害了，不是sci还投三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8bad1627254, createdName=医心唯你, createdTime=Thu Sep 27 00:00:00 CST 2018, time=2018-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561328, encodeId=fedf561328c4, content=有有呀睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab581969258, createdName=wsasdeffgcf, createdTime=Fri Sep 21 00:00:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561239, encodeId=9e66561239e0, content=oncotarget medicine scientific reports151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问151****6217暂无昵称 2018-09-16 00:00:00 发表: 其他三个水刊是什么请问, beContent=151****6217暂无昵称 2018-09-16 发表:: 其他三个水刊是什么请问, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/06/c27194fd2aa0b2c6e0ef45d9ce4b88b6.jpg, createdBy=703d2409831, createdName=睿禾, createdTime=Wed Sep 19 00:00:00 CST 2018, time=2018-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561133, encodeId=f2a65611332e, content=什么情况睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, beContent=睿禾 2018-09-13 00:00:00 发表: 有没有研究血液肿瘤方向的朋友？私信一下, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/25/6afda79338509feaac601aedee20ae29.jpg, createdBy=2f9d55421, createdName=cancerwj, createdTime=Mon Sep 17 00:00:00 CST 2018, time=2018-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561107, encodeId=c07256110e8a, content=其他三个水刊是什么请问137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上.瞎忙 2018-07-04 00:00:00 发表: 名声不好.四大水刊.好学校发了别人看不上., beContent=137****8670暂无昵称 2018-07-04 发表:: 名声不好.四大水刊.好学校发了别人看不上., objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a68d2223658, createdName=1210adeem17暂无昵称, createdTime=Sun Sep 16 00:00:00 CST 2018, time=2018-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560787, encodeId=42fe560e8759, content=难受。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Thu Sep 06 09:39:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560154, encodeId=858c560154c7, content=还有卵用？三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, beContent=三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9e32216429, createdName=pendrin_89355954, createdTime=Thu Aug 16 00:00:00 CST 2018, time=2018-08-16, status=1, ipAttribution=)]

2018-08-16 pendrin_89355954

还有卵用？三不猴 2018-08-06 00:00:00 发表:
4月28投稿，8月1号接收，主要是编辑非常好

三不猴 2018-08-06 00:00:00 发表: 4月28投稿，8月1号接收，主要是编辑非常好

275 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务